AURA Latest Press Releases

-- June 1, 2026 --

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma Globe Newswire 8:00 AM

-- May 19, 2026 --

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:50 PM

-- May 12, 2026 --

Aura Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 4:01 PM

-- May 11, 2026 --

Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights Globe Newswire 4:01 PM

-- May 5, 2026 --

Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 5:15 PM

-- May 4, 2026 --

Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants Globe Newswire 9:03 AM

Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 6:03 AM

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion Globe Newswire 6:01 AM

-- March 30, 2026 --

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- February 25, 2026 --

Aura Biosciences to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software